M&A / Deals Sun Pharma to acquire Organon for $11.75bn Pharmaceutical TechnologySun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash.Read full story pharminent April 27, 2026 (Last updated: April 27, 2026) Pharmaceutical Technology Sun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Sun sets out $11.75bn takeover play for OrganonNext: UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
